JVA Avidus Management Group, Inc.

Asantae Holdings International Inc. (TSX-V: JVA) ("Asantae" or the "Company") announces the closing of the first tranche of a non-brokered private placement (the "Private Placement").

Private Placement

Asantae is pleased to announce that it has closed the first tranche of the Private Placement pursuant to which the Company issued 1,550,000 units (each a "Unit") at a price of $0.15 per Unit for gross proceeds of $232,500.

Each Unit is comprised of one common share and one-half of one transferable common share purchase warrant (each a "Warrant") and each whole Warrant entitles the holder thereof to purchase an additional common share of the Company at an exercise price of $0.25 per share up to and including May 30, 2013.

The securities issued pursuant to the Private Placement and the shares issued in connection with the exercise of Warrants, if any, will be subject to a hold period expiring on April 1, 2012, in accordance with the policies of the TSX Venture Exchange and applicable securities laws.

Finder's fees of $20,925 cash have now been paid and 108,500 finder's warrants have now been issued in conjunction with the first tranche of the Private Placement. Each finder's warrant entitles the holder thereof to purchase one common share of the Company at an exercise price of $0.25 per share up to and including May 30, 2013.

The net proceeds of the Private Placement will be utilized by the Company for general corporate and working capital purposes.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

About Asantae

Asantae Holdings International Inc. (www.asantae.com) (TSX-V: JVA) is a producer and marketer of innovative nutritional products through direct and network marketing channels. The ingredients in Asantae's products have been shown to reduce chronic low-grade inflammation and oxidative stresses which, according to scientific and medical research, are the underlying conditions for most modern epidemic diseases (diabetes, heart disease, obesity, stroke, etc.).

Forward Looking Statements

Certain information in this news release is forward-looking within the meaning of certain securities laws, and is subject to important risks, uncertainties and assumptions. This forward-looking information includes, among other things, information with respect to the Company's beliefs, plans, expectations, anticipations, estimates and intentions, including the listing and trading of the Company's common shares on the Exchange. The words "may," "could," "should," "would," "suspect," "outlook," "believe," "anticipate," "estimate," "expect," "intend," "plan," "target" and similar words and expressions are used to identify forward-looking information. The forward-looking information in this news release describes the Company's expectations as of the date of this news release.

The results or events anticipated or predicted in such forward-looking information may differ materially from actual results or events. Material factors which could cause actual results or events to differ materially from such forward- looking information include, among others, the Company's ability to develop new products which will receive market acceptance, to receive market acceptance in new markets outside the United States, to engage and retain qualified key personnel, employees and affiliates, to obtain capital and credit and to protect its intellectual property rights.

The Company cautions that the foregoing list of material factors is not exhaustive. When relying on the Company's forward-looking information to make decisions, investors and others should carefully consider the foregoing factors and other uncertainties and potential events. The Company has assumed a certain progression, which may not be realized. It has also assumed that the material factors referred to in the previous paragraph will not cause such forward-looking information to differ materially from actual results or events. However, the list of these factors is not exhaustive and is subject to change and there can be no assurance that such assumptions will reflect the actual outcome of such items or factors.

THE FORWARD-LOOKING INFORMATION CONTAINED IN THIS NEWS RELEASE REPRESENTS THE EXPECTATIONS OF THE COMPANY AS OF THE DATE OF THIS NEWS RELEASE AND, ACCORDINGLY, IS SUBJECT TO CHANGE AFTER SUCH DATE. READERS SHOULD NOT PLACE UNDUE IMPORTANCE ON FORWARD-LOOKING INFORMATION AND SHOULD NOT RELY UPON THIS INFORMATION AS OF ANY OTHER DATE. WHILE THE COMPANY MAY ELECT TO, IT DOES NOT UNDERTAKE TO UPDATE THIS INFORMATION AT ANY PARTICULAR TIME.

For further information respecting the Company please contact: Dan Lundell CFO/COO 10153 E Hampton Ave, Ste 101 Mesa, Arizona, 85209 USA Phone: 480-278-8712 Fax: 480-383-6147